Open-Label Study of AG10 in Patients with Cardiomyopathy
Open-Label Study of AG10 in Patients with Cardiomyopathy
Active, not recruiting · NCT03536767 · Registry updated 2025-03-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Open-Label Study of AG10 in Patients with Cardiomyopathy | Amyloid Neuropathies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, amyloidosis, familial amyloid neuropathy, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, proteostasis deficiencies | Active, not recruiting | Phase 2 | 2025-03-13 | NCT03536767 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eidos Therapeutics, a BridgeBio company | 6 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Hospital | Boston | United States | 511 |
| Columbia University | New York | United States | 154 |
| Mayo Clinic | Rochester | United States | 664 |
| Medical University of South Carolina | Charleston | United States | 1 |
| Northwestern University | Chicago | United States | 727 |
| Oregon Health & Science University | Portland | United States | 261 |
| Stanford University | Palo Alto | United States | 161 |
| University of California San Francisco | San Francisco | United States | 144 |
| Yale University | New Haven | United States | 352 |